New Vircell COVID-19 Serology Assays

Last updated: 25th May, 2020

Products are for professional/laboratory use only.  Abacus dx is pleased to announce the launch of two new ELISA kits for the diagnosis of COVID-19 as well as two monotest kits for VirClia systems.

Serology allows confirmation of infection in symptomatic and asymptomatic patients.

Reference Description Kit Contents Insert Sheet
G1032 COVID-19 ELISA IgG 96 tests View here >
MA1032 COVID-19 ELISA IgM+IgA 96 tests View here >
VCM097 COVID-19 VIRCLIA IgG MONOTEST 24 tests View here >
VCM098 COVID-19 VIRCLIA IgM+IgA MONOTEST 24 tests View here >


Main features of Vircell COVID-19 serology assays

  • The use of SARS-CoV-2 recombinant antigens improves the performance of the kits.
  • IgM + IgA detection complements molecular tests when the viral load decreases or when false negatives are suspected due to unsuitable samples in patients with clear symptoms.
  • The combination of IgM + IgA significantly improves sensitivity since COVID-19 affects the mucous membrane. The early production of IgA antibodies in this kind of infections could be particularly high.
  • IgG detection allows monitoring and confirming recovery and possible immunity, when other molecular and serological markers become negative.

Find out more about Vircell COVID-19 ELISA Tests

View Flyer >

VirClia - Widest Panel for Infectious Serology - Australia

Download Brochure >

VirClia - Widest Panel for Infectious Serology - New Zealand

Download Brochure >

Contact us to find out more about Vircell VirClia

Contact Us Now >
Go BackGo Back